Showing results (41-50 of 68) with videos related to
Sort By:
Pageof 7
Biomaterials|February 9, 2016
The AGMA1 poly(amidoamine) inhibits the infectivity of herpes simplex virus in cell lines, in human cervicovaginal histocultures, and in vaginally infected miceManuela Donalisio, Paola Quaranta, Flavia Chiuppesi, et al.Journal of Cellular and Molecular Medicine|July 25, 2009
Fibroblast growth factor 2-antagonist activity of a long-pentraxin 3-derived anti-angiogenic pentapeptideDaria Leali, Roberta Bianchi, Antonella Bugatti, et al.Pharmaceuticals (Basel, Switzerland)|July 27, 2024
A Dynamic and Effective Peptide-Based Strategy for Promptly Addressing Emerging SARS-CoV-2 Variants of ConcernMichela Murdocca, Isabella Romeo, Gennaro Citro, et al.International Journal of Molecular Sciences|March 20, 2020
Role of Autophagy in Von Willebrand Factor Secretion by Endothelial Cells and in the In Vivo Thrombin-Antithrombin Complex Formation Promoted by the HIV-1 Matrix Protein p17Antonella Bugatti, Stefania Marsico, Pietro Mazzuca, et al.Plos One|October 12, 2013
Peptide-derivatized SB105-A10 dendrimer inhibits the infectivity of R5 and X4 HIV-1 strains in primary PBMCs and cervicovaginal histoculturesIsabella Bon, David Lembo, Marco Rusnati, et al.Free Radical Biology & Medicine|November 6, 2012
Membrane association of peroxiredoxin-2 in red cells is mediated by the N-terminal cytoplasmic domain of band 3Alessandro Matte, Mariarita Bertoldi, Narla Mohandas, et al.Molecular Cancer Therapeutics|December 17, 2008
alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomersMirella Belleri, Domenico Ribatti, Monica Savio, et al.Biochemical Pharmacology|October 15, 2015
Biochemical characterization of EphA2 antagonists with improved physico-chemical properties by cell-based assays and surface plasmon resonance analysisCarmine Giorgio, Simonetta Russo, Matteo Incerti, et al.Diabetes|February 20, 2015
Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic RetinopathySara Rezzola, Massimo Dal Monte, Mirella Belleri, et al.Molecular Cancer Therapeutics|February 4, 2012
The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonistSandra Liekens, Annelies Bronckaers, Mirella Belleri, et al.Pageof 7